Clinical and Translational Pre-doctoral training in Alzheimer's Disease and Related Dementias

阿尔茨海默病和相关痴呆症的临床和转化博士前培训

基本信息

  • 批准号:
    10475693
  • 负责人:
  • 金额:
    $ 7.77万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2018
  • 资助国家:
    美国
  • 起止时间:
    2018-09-01 至 2024-04-30
  • 项目状态:
    已结题

项目摘要

ABSTRACT Alzheimer's disease is a devastating and ultimately fatal neurodegenerative disorder that severely compromises normal cognition and behavior. Costs associated with caring for individuals suffering from AD now exceed 250 billion dollars annually and are expected to rise exponentially in the foreseeable future. Despite this staggering statistic, there exist few treatments and no cures for AD and related dementias. Significant advances in the treatment of AD will require scientists to cross traditional boundaries between disciplines. Indeed, there is increasing recognition that AD is pathologically, genetically, and/or clinically linked to a number of other dementing diseases. Moreover, it is clear that a fuller understanding of how primary risk factors and co- morbidities in AD influence disease progression could reveal novel targets for improving patient outcomes. The overarching goal of this proposal is to build upon outstanding infrastructure for neuroscience training and the vast expertise in AD research at the University of Florida to create a pre-doctoral training program that will foster the development of the next generation of AD researchers and equip them with the broad perspective and scientific skills necessary to make true advances in the treatment of this devastating and complex disease. Trainees for this program will be selected from a pool of outstanding students from diverse backgrounds who are admitted into one of two graduate programs—a biomedical science program and a clinical health psychology program. Trainees would benefit from (1) intensive mentorship in research concepts and methodology, scientific analysis and interpretation (2) opportunities to train and interact with world-class faculty who are leading authorities in the field of AD, aging and co-morbidities of this disease (3) diverse dissertation committees that include multiple mentors with distinct realms of expertise in order to promote broad-based and comprehensive training in AD research (4) assistance integrating large scale, open source data supported by NIA such as AMP- AD and ADNI into their own research (5) personalized mentorship in professional development including grant writing, oral presentations, and networking. Finally, this training program is designed to maximize interactions among trainees and training faculty that cross levels of analysis and to create a rigorous but supportive training environment that will prepare trainees for success in laboratory science and provide them with the knowledge and skills required to make a significant impact in advancing treatments for AD.
抽象的 阿尔茨海默病是一种毁灭性的、最终致命的神经退行性疾病,会严重危害健康 正常的认知和行为。护理 AD 患者的相关费用现已超过 250 每年数十亿美元,预计在可预见的未来将呈指数级增长。尽管这令人震惊 据统计,AD 及相关痴呆症的治疗方法很少,也无法治愈。重大进展 AD 的治疗需要科学家跨越学科之间的传统界限。确实,有 人们越来越认识到 AD 在病理、遗传和/或临床上与许多其他疾病有关 痴呆症。此外,很明显,更全面地了解主要风险因素和共同风险因素如何 AD 的发病率对疾病进展的影响可能会揭示改善患者预后的新目标。这 该提案的总体目标是建立神经科学培训和神经科学培训的杰出基础设施 佛罗里达大学在AD研究方面的丰富专业知识创建了一个博士前培训计划,该计划将促进 培养下一代 AD 研究人员,并为他们提供广阔的视野和 在治疗这种毁灭性的复杂疾病方面取得真正进展所必需的科学技能。 该计划的学员将从来自不同背景的优秀学生中选拔 被两个研究生课程之一录取——生物医学科学课程和临床健康心理学课程 程序。受训者将受益于(1)研究概念和方法、科学 分析和解释 (2) 与世界一流的领先教师进行培训和互动的机会 AD、衰老和该疾病的合并症领域的权威 (3) 不同的论文委员会 包括多名具有不同专业领域的导师,以促进基础广泛和全面的 AD 研究培训 (4) 协助整合 NIA 支持的大规模开源数据,例如 AMP- AD 和 ADNI 投入自己的研究 (5) 专业发展方面的个性化指导,包括资助 写作、口头演讲和网络。最后,该培训计划旨在最大限度地提高互动 在学员和培训教师之间进行跨层次的分析,并创建严格但支持性的培训 为学员在实验室科学方面取得成功做好准备并为他们提供知识的环境 以及在推进 AD 治疗方面产生重大影响所需的技能。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

JENNIFER Lynn BIZON其他文献

JENNIFER Lynn BIZON的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('JENNIFER Lynn BIZON', 18)}}的其他基金

Mechanisms and therapeutic potential of vagus nerve stimulation in aging and Alzheimer’s disease
迷走神经刺激在衰老和阿尔茨海默病中的机制和治疗潜力
  • 批准号:
    10209090
  • 财政年份:
    2021
  • 资助金额:
    $ 7.77万
  • 项目类别:
Effects of cannabis on age-related cognitive decline and Alzheimers disease pathology
大麻对与年龄相关的认知能力下降和阿尔茨海默病病理学的影响
  • 批准号:
    10316617
  • 财政年份:
    2021
  • 资助金额:
    $ 7.77万
  • 项目类别:
Effects of cannabis on age-related cognitive decline and Alzheimers disease pathology
大麻对与年龄相关的认知能力下降和阿尔茨海默病病理学的影响
  • 批准号:
    10633300
  • 财政年份:
    2021
  • 资助金额:
    $ 7.77万
  • 项目类别:
Effects of cannabis on age-related cognitive decline and Alzheimers disease pathology
大麻对与年龄相关的认知能力下降和阿尔茨海默病病理学的影响
  • 批准号:
    10469575
  • 财政年份:
    2021
  • 资助金额:
    $ 7.77万
  • 项目类别:
Immunotherapy targeting the HPA axis in Alzheimer's disease
针对阿尔茨海默病 HPA 轴的免疫疗法
  • 批准号:
    10846355
  • 财政年份:
    2019
  • 资助金额:
    $ 7.77万
  • 项目类别:
Clinical and Translational Pre-doctoral training in Alzheimer's Disease and Related Dementias
阿尔茨海默病和相关痴呆症的临床和转化博士前培训
  • 批准号:
    10228736
  • 财政年份:
    2018
  • 资助金额:
    $ 7.77万
  • 项目类别:
2RO1AG029421 Neural Mechanisms of Age-related cognitive decline
2RO1AG029421 与年龄相关的认知能力下降的神经机制
  • 批准号:
    8852384
  • 财政年份:
    2014
  • 资助金额:
    $ 7.77万
  • 项目类别:
Neural Mechanisms of Cognitive Decline in Aging
衰老过程中认知能力下降的神经机制
  • 批准号:
    9250037
  • 财政年份:
    2007
  • 资助金额:
    $ 7.77万
  • 项目类别:
Basal forebrain and cognitive aging: Novel experimental and theraptutic avenues
基底前脑和认知衰老:新的实验和治疗途径
  • 批准号:
    8180233
  • 财政年份:
    2007
  • 资助金额:
    $ 7.77万
  • 项目类别:
Basal forebrain and cognitive aging: Novel experimental and theraptutic avenues
基底前脑和认知衰老:新的实验和治疗途径
  • 批准号:
    7627219
  • 财政年份:
    2007
  • 资助金额:
    $ 7.77万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了